Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to give written consent to participate, in line with Swiss law and international clinical trial standards, before any trial procedures begin
- People who have a medical reason to receive radiotherapy to the head and neck area, regardless of the type of tumour
- People who are 18 years of age or older
- People who have a Karnofsky performance score of 70 or above — this is a scale doctors use to measure a person's general health and ability to carry out daily activities (confirm with trial site)
- People who are willing and able to attend scheduled visits and follow the trial procedures as required
Who may not be able to join:
- People who have previously had radiation treatment to the head or neck area
- People who are currently pregnant or breastfeeding
- People who plan to become pregnant during the trial period
- Female participants of childbearing potential who are not using, and are not willing to use, a reliable method of contraception throughout the trial (such as the pill, injections, implants, or an intrauterine device)
- People with a known or suspected history of not following medical instructions, or with drug or alcohol misuse concerns
- People who would be unable to follow the trial procedures, for example due to a language barrier
- The trial investigator, their family members, employees, or others in a dependent relationship with the investigator
- People with tumours in certain locations — specifically the nasopharynx or sinonasal area, or people whose treatment area falls within 5 mm of the eyes or spinal cord
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Panagiotis Balermpas, Prof. Dr., University of Zurich
Phone: +41 44 255 35 66
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient discomfort, anxiety and pain; overall preference
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.